They nearly lost him twice, says Kelly Gillion of her son Zeus, who was diagnosed with the potentially fatal condition ADA-SCID in the first weeks of his life. Until now the only commercial treatment for the condition has been a bone marrow transplant, and many die before a donor is found. But last week, a gene therapy to treat it was rubber-stamped for approval by a committee of the European Medicines Agency, potentially giving all patients in Europe access to a treatment that enables them to build lifelong immune systems with the help of transplanted genes
© 2001-2024 Fundación Dialnet · Todos los derechos reservados